SCHEMBL4466466

SCHEMBL4466466

CCOC(=O)CC(=O)c1ccc(F)c(Cl)c1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
HPGD P15428 1/20 0.41
MGLL Q99685 1/20 0.41
MGAM O43451 1/20 0.40
GAA P10253 1/20 0.40
SI P14410 1/20 0.40
MGAM2 Q2M2H8 1/20 0.40
NLRP3 Q96P20 2/20 0.40
MIF P14174 1/20 0.40
PKM P14618 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 2/20 0.38
MAPT P10636 2/20 0.37
CYP1A2 P05177 2/20 0.37
LMNA P02545 2/20 0.37
ALOX15 P16050 1/20 0.37
CYP2C9 P11712 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL312535 0.86 CES2 (0.47) TDP1MEN1KMT2AHPGDMGLL
SCHEMBL7503032 0.86 MIF (0.38) TDP1MEN1KMT2AHPGDMGLL
SCHEMBL28823305 0.82 NLRP3 (0.49) TDP1MEN1KMT2AMGLLMGAM
SCHEMBL30736446 0.82 MEN1 (0.41) TDP1MEN1KMT2AHPGDMGLL
SCHEMBL3190199 0.82 MEN1 (0.41) TDP1MEN1KMT2AHPGDMGLL
SCHEMBL6318986 0.82 MEN1 (0.50) TDP1MEN1KMT2AHPGDMGLL
SCHEMBL116517 0.81 MEN1 (0.50) TDP1MEN1KMT2AHPGDMGLL
SCHEMBL2199535 0.81 MEN1 (0.51) TDP1MEN1KMT2AHPGDMGLL
SCHEMBL3717230 0.79 NLRP3 (0.49) TDP1MEN1KMT2AMGLLMGAM
SCHEMBL10616642 0.79 MEN1 (0.41) TDP1MEN1KMT2AHPGDMGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7482454-B2 Antimicrobial quinolones, their compositions, and uses THE PROCTER & GAMBLE COMPANY (US) 2009-01-27 US disclosed
US-20060100436-A1 Antimicrobial quinolones, their compositions, and uses WARNER CHILCOTT COMPANY, LLC 2006-05-11 US disclosed
US-6329391-B1 ANTIBIOTICS, BACTERICIDES USING QUINOLONES THE PROCTER & GAMBLE CO. 2001-12-11 US disclosed
EP-1015445-A1 ANTIMICROBIAL QUINOLONES, THEIR COMPOSITIONS AND USES THE PROCTER & GAMBLE COMPANY (US) 2000-07-05 EP disclosed
WO-1999014214-A1 ANTIMICROBIAL QUINOLONES, THEIR COMPOSITIONS AND USES THE PROCTER & GAMBLE COMPANY (US) 1999-03-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060100436-A1 Antimicrobial quinolones, their compositions, and uses Q6ZSR9, RECQL, QARS1 TDP1 3511/4885MEN1 2135/4885KMT2A 3842/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.